Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Dermatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Total Body Photography with Body Mapping
February 2025
In this video, Robyn Siperstein emphasises the importance of high-quality total body photography in modern cosmetic and medical…
Read more
26 Oct 2016
An interview with Prof Torello M. Lotti at the 2016 EADV Congress
An interview with Prof Torello M. Lotti (Professor and Chair of Dermatology, University of Rome) at the 2016 EADV Congress, Vienna, Austria.
26 Oct 2016
Congress Review – EADV 2016
Don’t miss our congress review in our EMJ Dermatology 4.1 2016 eJournal, coming soon…
14 Jun 2016
Overview of ZPL-3893787 (ZPL-389) clinical trial for atopic dermatitis
Thomas Werfel, MD, from Hannover Medical School, Hannover, Germany, gives an overview of a phase 2a proof-of-concept clinical trial evaluating ZPL…
14 Jun 2016
Phase 2a trial of ZPL-3893787 (ZPL-389), a histamine H4 receptor antagonist, for atopic dermatitis
Thomas Werfel, MD, from Hannover Medical School, Hannover, Germany, discusses the design and outcomes from a phase 2a proof-of-concept clinical trial…
14 Jul 2015
Supporting CKD Patients at Home
Baxter Symposium from the 52nd European Renal Association – European Dialysis and Transplant Association Congress 2015.
Loading posts...
« Previous
1
…
3
4
5